ClinicalTrials.gg

IDRX, Inc. clinical trials

Acquired by GlaxoSmithKline, Feb 21, 2025 · source ↗

The registry lists 1 studies whose lead sponsor is IDRX, Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 5, 2026.

Before and after it joined GlaxoSmithKline

First submitted before IDRX, Inc. became part of GlaxoSmithKline
1
First submitted after IDRX, Inc. became part of GlaxoSmithKline
0
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs IDRX, Inc.’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.

Studies, none open

Coming up

1 of IDRX, Inc.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. 1M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

All 1 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Under way, not recruiting1100%

Phase

  • Phase 11

Where

  • France1
  • Belgium1
  • United States1
  • China1
  • Germany1
  • Japan1

Over the years

  1. 122
  2. 23
  3. 24
  4. 25
  5. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • IDRX, Inc., a wholly owned subsidiary of GSK, LLC1 study

Something wrong with this grouping? Tell us on the GlaxoSmithKline page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All GlaxoSmithKline studies →